SMO and neoplasm: Although they described a transient ‘enhancement’ of tumor angiogenesis by Smo inhibition, the reduction in SMA+ myofibroblasts may limit the maturation of neovasculature through a depletion of vascular pericytes, which in turn consequently ‘destabilize’ tumor-associated neovessels as we and others [58] observed.